Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™
ABIM Diplomates - maximum of 0.25 ABIM MOC points
Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)
Physician Assistant - 0.25 AAPA hour(s) of Category I credit
IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit
This activity is intended for obstetricians/gynecologists/women’s health clinicians, family medicine/primary care clinicians, internists, nurses, physician assistants, and other members of the health care team caring for patients with or at risk for postpartum hemorrhage.
The goal of this activity is for healthcare team members to be better able to describe temporal trends in and risk factors for postpartum hemorrhage and the association of risk factors with postpartum hemorrhage-related interventions such as blood transfusion and peripartum hysterectomy.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 02/03/2024. PAs should only claim credit commensurate with the extent of their participation.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 2/3/2023
Valid for credit through: 2/3/2024, 11:59 PM EST
processing....
Postpartum hemorrhage is the leading cause of maternal mortality globally and a significant cause of US maternal morbidity and mortality. Risk factors include clinical factors causing uterine atony, uterine overdistention, cesarean delivery, uterine fibroids, and advanced age.
Many of these risk factors appear to be increasing in the population. Recent US population trends in postpartum hemorrhage risk and outcomes in the setting of recent clinical management changes are poorly characterized.
The rate of postpartum hemorrhage for hospital deliveries in the United States increased significantly over the course of a 20-year period, according to data from more than 76 million delivery hospitalizations from the National Inpatient Sample.
Postpartum hemorrhage remains the leading cause of maternal morbidity and mortality worldwide, and many clinical- and patient-level risk factors appear to be on the rise, write Chiara M. Corbetta-Rastelli, MD, from the University of California, San Francisco, and colleagues.
Although practice changes have been introduced to reduce postpartum hemorrhage, recent trends in postpartum hemorrhage risk and outcomes in the context of such changes as hemorrhage safety bundles have not been examined, they said.
In a study published in Obstetrics & Gynecology, the researchers reviewed data from hospitalizations for females aged 15 to 54 years for deliveries between 2000 and 2019, using the National Inpatient Sample.[1] They used a regression analysis to estimate average annual percentage changes (AAPC). Their objectives were to characterize trends and to assess the association between risk factors and the occurrence of postpartum hemorrhage and related interventions. Demographics, clinical factors, and hospital characteristics were mainly similar between the group of patients with postpartum hemorrhage and those with no postpartum hemorrhage.
Approximately 3% (2.3 million) of 76.7 million hospitalizations for delivery were complicated by postpartum hemorrhage during the study period, and the annual rate increased from 2.7% to 4.3%.
Overall, 21.4% of individuals with delivery hospitalizations complicated by postpartum hemorrhage had 1 postpartum risk factor and 1.4% had 2 or more risk factors. The number of individuals with at least 1 risk factor for postpartum hemorrhage increased significantly, from 18.6% to 26.9%, during the study period, with an annual percentage change of 1.9%.
Compared with deliveries in individuals without risk factors, individuals with 1 risk factor had slightly higher odds of postpartum hemorrhage (odds ratio, 1.14), but those with 2 or more risk factors were more than twice as likely to experience postpartum hemorrhage as those with no risk factors (odds ratio, 2.31).
The researchers also examined the association of specific risk factors and interventions related to hemorrhage--notably, blood transfusion and peripartum hysterectomy. Blood transfusions in individuals with postpartum hemorrhage increased from 5.4% to 16.7% between 2000 and 2011 (AAPC, 10.2%) and then decreased from 16.7% to 12.6% from 2011 to 2019 (AAPC, −3.9%).
Peripartum hysterectomy in the study population increased from 1.4% to 2.4% from 2000 to 2009 (AAPC 5.0%), remained steady from 2009 to 2016, and then decreased from 2.1% to 0.9% from 2016 to 2019 (AAPC, −27%).
Other risk factors associated with postpartum hemorrhage itself and with blood transfusion and hysterectomy in the setting of postpartum hemorrhage included prior cesarean delivery with placenta previa or accreta, placenta previa without prior cesarean delivery, and antepartum hemorrhage or placental abruption, the researchers note.
“In addition to placental abnormalities, risk factors such as preeclampsia with severe features, polyhydramnios, and uterine leiomyomas demonstrated the highest rates of increase in our data,” they write in their discussion. These trends may lead to continuing increases in postpartum hemorrhage risk, which was not fully explained by the increase in risk factors seen in the current study, the researchers said.
The study findings were limited by several factors, including the use of billing codes that could lead to misclassification of diagnoses, as well as possible differences in the definition and coding for postpartum hemorrhage among hospitals, the researchers note. Other limitations were the exclusion of cases of readmission for postpartum hemorrhage and lack of clinical details involving use of medications or nonoperative interventions, they said.
Notably, the study finding of stable to decreasing peripartum hysterectomy rates in hospitalized patients with postpartum hemorrhage conflicts with another recent study showing an increase in peripartum hysterectomy from 2009 to 2020, but this difference may reflect changes in billing, indications for hysterectomy, or study modeling, they note.[2]
The current study was strengthened by the use of a large database to analyze population trends, a contemporary study period, and the inclusion of meaningful outcomes such as peripartum hysterectomy.
The shift in blood transfusion and peripartum hysterectomy may reflect the implementation of protocols to promote early intervention and identification of postpartum hemorrhage, they conclude.
Interventions can have an effect“Hemorrhage remains a leading cause of maternal mortality in the United States, and blood transfusion is the most common severe maternal morbidity,” Catherine M. Albright, MD, associate professor of maternal-fetal medicine at the University of Washington, Seattle, said in an interview. “It is important to understand the current state, especially given that many hospitals have implemented policies and procedures to better identify and treat postpartum hemorrhage,” she said.
Dr Albright added, “I was pleased to see that they did not just look at a diagnosis of postpartum hemorrhage but rather also looked at complications arising from postpartum hemorrhage, such as blood transfusion or hysterectomy.”
Postpartum hemorrhage is often a clinical diagnosis that uses estimated blood loss, which is a notoriously inaccurate measure, said Dr Albright. “Additionally, the definitions of postpartum hemorrhage, as well as the [International Classification of Diseases] codes, changed during the time period of the study,” she noted. “These factors all could lead to both underreporting and overreporting of the true incidence of postpartum hemorrhage. Blood transfusion and hysterectomy are more objective outcomes and demonstrate true morbidity,” she said.
“Most of the risk factors that are listed in the article are not modifiable during that pregnancy,” said Dr Albright. For example, a history of a prior cesarean or having a twin pregnancy is not something that can be changed, she said. “Many of the other risk factors or associated clinical factors, such as obesity, chronic hypertension, and pregestational diabetes, are modifiable, but before pregnancy. Universal and easy access to primary medical care prior to and between pregnancies may help to mitigate some of these factors,” she noted.
Looking ahead, “It would be helpful to ensure that these types of data are available at the state and hospital level; this will allow for local evaluation of programs that are in place to reduce postpartum hemorrhage risk and improve identification and treatment,” Dr Albright said.
The study received no outside funding. Dr Corbetta-Rastelli and Dr Albright have disclosed no relevant financial relationships.
Obstet Gynecol. 2023;141(1):152-161